Footprints in primary care

Testing the feasibility of a consultation-level intervention for patients in primary care who attend more significantly than the norm with clinically inexplicable symptoms

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN62939408

Enrollment

Registered

2015-06-24

Start date

2015-07-01

Completion date

Unknown

Last updated

2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Primary Care

Interventions

1. Intervention: GP training in the BATHE technique and assignment of eligible patients to a 'usual' GP 2. Control: Treatment as usual BATHE is an acronym (Background,

Practices are randomised and eligible patients invited to participate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Registered patient at one of the study practices 2. Patients aged =18 years 3. Within top 3% attenders in the 12 months prior to commencement of records search

Exclusion criteria

Exclusion criteria: 1. Patients whose attendance can be accounted for by a diagnosed physical or mental illness 2. Patients with life-threatening illness such as cancer 3. Patients over 80 years with 4+medical problems 4. Patients at high risk of hospital admission 5. Patients undergoing distressing one-off events such as bereavement 6. Vulnerable adults and patients without capacity to provide informed consent

Design outcomes

Primary

Measure	Time frame
The primary outcome measure will be difference in number of consultations (including consultation type), hospital admissions, tests/investigations, referrals and prescriptions extracted from the patient record between baseline and 12 months. items not available from this source will be obtained using a specially designed patient questions to be completed at 6 and 12 months.	—

Secondary

Measure	Time frame
Secondary outcomes to be measured at baseline and 12 months include patient health-related quality of life measured using the EQ-5D-5L; the SF-12 Health Survey; the Patient Health Questionnaire (PHQ-9); the Generalised Anxiety Disorder (GAD-7) scale; the PHQ-15 for monitoring somatic symptom severity; the PAM-13 Patient Activation Measure to measure knowledge, skills and confidence integral to managing one’s own health and healthcare; and a patient satisfaction measure based on the GP Patient Survey. At months 3 and 6 the questionnaire will include the EQ-5D-5L, PHQ-15 and PAM-13 only At 6 and 12 months, questionnaires will also be used to obtain: information about the use of social services; personal out-of-pocket expenditure by patients and their carers due to their health such as over-the-counter medicine and remedies, travel costs, and expenditure on prescriptions; and wider costs to society such as the use of voluntary services and time off work.	—

Measure

Time frame

Secondary outcomes to be measured at baseline and 12 months include patient health-related quality of life measured using the EQ-5D-5L; the SF-12 Health Survey; the Patient Health Questionnaire (PHQ-9); the Generalised Anxiety Disorder (GAD-7) scale; the PHQ-15 for monitoring somatic symptom severity; the PAM-13 Patient Activation Measure to measure knowledge, skills and confidence integral to managing one’s own health and healthcare; and a patient satisfaction measure based on the GP Patient Survey. At months 3 and 6 the questionnaire will include the EQ-5D-5L, PHQ-15 and PAM-13 only At 6 and 12 months, questionnaires will also be used to obtain: information about the use of social services; personal out-of-pocket expenditure by patients and their carers due to their health such as over-the-counter medicine and remedies, travel costs, and expenditure on prescriptions; and wider costs to society such as the use of voluntary services and time off work.

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 20, 2026